Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Gynecol Oncol. 2019 Oct 22;155(3):483–488. doi: 10.1016/j.ygyno.2019.10.008

Table 3.

Univariate analysis of IHC markers and correlation with patient and tumor factors in ovarian cohort

Hazard Ratio 95% CI p value
PD-1 TILs
 Negative/rare Referent
 Elevated 1.29 0.91 – 1.84 0.154
PD-L1 IHC
 ’0% Referent
 More than 0% 1.26 0.91 – 1.75 0.168
PD-1 positive lymphocytes
 ’0 Referent
 More than 0 0.91 0.323 – 2.59 0.8662
PD-L1 CPS
 <1 Referent
 ≥1 0.89 0.303 – 2.59 0.8245

Abbreviations: TILS: tumor infiltrating lymphocytes; CPS: combined positive score; IHC: Immunohistochemistry